Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

OUR INSANE HOUSE PARTY GONE WRONG! -You Should Know Podcast- 1h 21m · 21 Sep 2026 · You Should Know Podcast

Where is Austin Tice? 1. 'We believe he’s alive' 34 min · 21 Sep 2026 · The Documentary Podcast

Arsenal battered in Brighton as Manchester City go clear: Football Weekly 54 min · 21 Sep 2026 · Football Weekly

NPR News: 09-21-2026 8AM EDT 4 min · 21 Sep 2026 · NPR News Now

The Data Gold Rush_ Who Really Owns Your Digital Footprint 2 min · 21 Sep 2026 · Conspiracy Theories Exploring The Unseen

8AM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded15 May 2025

Publisherfeeds.buzzsprout.com

Handlerec:1648140

Show notes

Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in